www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Nation
Pharma firms start work on H1N1 vaccine
2009-Jul-7 11:03:08

China has announced that it would stockpile the H1N1 flu vaccine for 1 percent of the population by Oct 1, even as the 10 designated Chinese vaccine producers are getting busy with development and clinical trials.

The stockpile of 13 million injections will be used as a preventive measure to counter any sudden outbreak of the flu, Liang Wannian, deputy director of the Ministry of Health's contingency office, said.

He said the flu vaccine would be chiefly targeted at high-risk groups -- people with prevalent illnesses and pregnant women.

The first batch of China's H1N1 flu vaccine, developed by these 10 companies, is expected to be ready by the end of the month, and would undergo a two-month clinical trial before it is made available to the public, he said.

The 10 local vaccine makers include Beijing Sinovac Biotech Co Ltd, Zhuhai Hualan Biological Engineering Inc and Shenzhen Neptunus Interlong Bio-tech Co Ltd.

Sinovac announced recently that it had completed construction of the H1N1 virus seed bank necessary to produce a virus antigen.

The company received the seed virus from the US Center for Disease Control on June 8 and started producing the H1N1 vaccine the same day.

Sinovac said it expected to complete production of the first batch and initiate clinical trials of the vaccine by the end of this month. The flu vaccine has been named PANFLU.

The company got 100 million yuan on June 29 as loan from the Bank of Beijing, which will be used to purchase pharmaceutical raw material and for expanding its manufacturing facility, according to Sinovac Chairman, President and CEO Yin Weidong. The company's current annual vaccine production capacity is between 20 million and 30 million doses.

Shenzhen-listed Hualan Biological Engineering Inc said on July 1 that its equity holding subsidiary Hualan Biological Vaccine Co Ltd, a H1N1 vaccine developer, had borrowed 20 million yuan from each of the two shareholders of the parent company to fund its vaccine development effort.

Hualan can now manufacture nearly 200 million doses annually.

Li Yingpeng, a pharmaceutical analyst at Galaxy Securities, said 13 million doses of the H1N1 vaccine implied the vaccine makers could net a business of over 300 million yuan, as the average market price of other vaccines in China was around 30 yuan per dose.

"Though it seems these 10 companies have grabbed the huge business opportunities, they are, at the same time, shouldering high risks," Li said.

He said since the evolution of the H1N1 flu could not be predicted accurately, the returns on the huge investment required for development of the vaccine and clinical trials could not be guaranteed.

[Jump to ]
Nation | Biz | Comment | World | Celebrity | Odds | Sports | Travel | Health
ChinaDaily Mobile News
m.chinadaily.com.cn
To subscribe to China Daily, call 010-64918763 or email to circu@chinadaily.com.cn
主站蜘蛛池模板: 美女视频永久黄网站免费观看韩国 | 欧美一级在线观看视频 | 久久精品国产精品亚洲精品 | 亚洲热视频 | 国产黄三级三·级三级 | 女人张开双腿让男人 | 色偷偷88欧美精品久久久 | 美女视频大全视频a免费九 美女视频大全网站免费 | 国产ssss在线观看极品 | 久久精品国产亚洲7777 | 九九视频在线播放 | a毛片免费看 | 欧美高清日韩 | 韩国精品一区二区三区四区五区 | 国产欧美一区二区三区精品 | 91精品自在拍精选久久 | 亚洲欧美日韩国产精品26u | 国产成在线观看免费视频 | 国产高清a毛片在线看 | 欧美精品片在线观看网站 | 国产日本韩国 | 久久国产精品岛国搬运工 | 成人亚洲精品一区 | 国产中文字幕在线观看 | 香蕉久久夜色精品国产 | 国产视频在线免费观看 | 欧美乱一级在线观看 | 成人在线黄色 | 久久午夜影院 | 在线观看亚洲精品专区 | 国产在线观看免费人成小说 | 99在线视频精品费观看视 | 亚洲aa| 国产视频高清在线观看 | 成人午夜做爰视频免费看 | 日本一级做人免费视频 | 在线看免费观看韩国特黄一级 | 97成人精品视频在线播放 | 免费国产不卡午夜福在线观看 | 亚洲精品社区 | 麻豆影音 |